« previous next »
Pages: [1]

Author Topic: (Abst.) 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on MRI use in PwMS  (Read 45 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on MRI use in PwMS
« on: June 18, 2021, 07:00:49 pm »
The MS experts seem to be backing off from the use of the gadolinium contrast agent in MRIs due to safety concerns.


From PubMed (June 14, 2021), "2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis":


https://pubmed.ncbi.nlm.nih.gov/34139157/
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
8 Replies
191 Views 		Last post July 24, 2020, 08:32:31 am
by agate
0 Replies
84 Views 		Last post September 22, 2020, 08:04:07 pm
by agate
0 Replies
36 Views 		Last post October 22, 2020, 08:52:36 pm
by agate
0 Replies
28 Views 		Last post November 15, 2021, 09:20:43 pm
by agate
0 Replies
29 Views 		Last post September 14, 2022, 09:15:15 pm
by agate